Quick access :

Mérieux Equity Partners teams up with ICG to acquire leading Italian generic company, DOC Generici

08/04/2019

DOC Generici is Italy’s largest independent generic pharmaceutical company.

Inscripta expands Series C Financing Round to $105.5 million

04/04/2019

Existing investors have agreed to contribute an additional $20 million to its previously announced Series C funding round.

Merieux Equity Partners to enter in exclusive negotiations for the sale of their stake in Amplitude Laser Group to L-GAM

28/03/2019

Amplitude Laser Group has transformed itself into a global leader with a truly international footprint.

Xeris Pharmaceuticals presents new Clinical and Economic Impact Data on its Developmental Ready-to-use Glucagon

25/03/2019

Data from a Phase 2 study in congenital hyperinsulinism (CHI) reinforce the utility of Xeris’ ready-to-use, liquid-stable Glucagon.

LNA Santé acquires the Moulin Vert Rehabilitation Center

15/03/2019

The Moulin Vert facility specializes in the treatment of respiratory diseases and heart disorders

Xeris Pharmaceuticals doses first patient in Phase 2 trial evaluating its ready-to-use Glucagon to address Exercise-Induced Hypogycemia

15/03/2019

Xeris has begun dosing Type 1 diabetes patients with its stable liquid Glucagon.

Ivantis announces 24-month results of Landmark Clinical Trial

14/03/2019

International multi-center study compares effectiveness of the Hydrus® Microstent to two Glaukos iStent® Trabecular Micro-Bypass stents in standalone glaucoma.

Biobest's PMV®-01: First Vaccine against PepMV authorized in North America

14/03/2019

PMV®-01 is the first plant vaccine against Pepino Mosaic Virus (PepMV) in tomato authorized by EPA and PMRA.

Amplitude launches the Satsuma Display

13/03/2019

Satsuma Display is the most compact air-cooled femtosecond laser on the market, offering 4 individual outputs.